Coste del tratamiento del cáncer de mama por estadío clínico en el País Vasco

Arrospide, Arantzazu; Soto-Gordoa, Myriam; Acaiturri, Teresa; López-Vivanco, Guillermo; Abecia, Luis Carlos; Mar, Javier.
Rev. esp. salud pública ; 89(1): 93-97, ene.-feb. 2015. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-181423

Documentos relacionados

  1. The Global Macroeconomic Burden of Breast Cancer: Implications for Oncologic Surgery.
  2. Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
  3. Cost-effectiveness of radioguided occult lesion localization using 125I seeds versus hookwire localization before breast-conserving surgery for non-palpable breast cancer.
  4. The impact of the introduction of generic aromatase inhibitors on adherence to hormonal therapy over the full course of 5-year treatment for breast cancer.
  5. Awardee-specific economic costs of providing cancer screening and health promotional services to medically underserved women eligible in the National Breast and Cervical Cancer Early Detection Program.
  6. Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
  7. Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis.
  8. A Systematic Review of Utility Score Assessments in the Breast Surgery Cost-Analysis Literature.
  9. Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer.
  10. Current Practice and Perceptions Regarding Cost Communication in Breast Cancer Reconstruction: Survey Results of the American Society of Plastic Surgeons.